Cardiac Membrane Biology Laboratory

The Cardiac Membrane Biology Laboratory aims to improve the lives of people suffering cardiac related health issues.

Our research focuses on one of the body’s most crucial molecules – a molecule which is vital for the contraction of heart cells and therefore the pumping of the heart. As we develop a better understanding of this molecule through laboratory-based experiments, we explore treatments for heart failure, irregular heartbeat and heart damage following cancer treatment.

Our laboratory-based research has led to the discovery of a new potential treatment for heart failure. We are about to begin a clinical trial of this approach with our collaborators based in Denmark.

Lead

Prof Helge Rasmussen.

Chair of Cardiology
Medicine, Northern Clinical School

People

Dr Elisha Hamilton, PhD

Laboratory Manager
Medicine, Northern Clinical School

Network

Projects

PREVENTION OF CARDIAC SIDE EFFECTS OF CANCER TREATMENT

This project will investigate a new drug combination therapy that has potential benefits in cancer treatment induced heart failure by targeting the sodium/potassium pump function.

A NEW DRUG COMBINATION THERAPY FOR HEART FAILURE

This project will investigate a drug combination therapy that has potential benefits in heart failure treatment by targeting the sodium/potassium pump function.

Publications